0.0300
0.0000
(0.00%)
At close: September 17 at 4:00:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
157,533
151,663
234,834
266,782
Total Liabilities Net Minority Interest
11,829
14,195
7,295
12,867
Total Equity Gross Minority Interest
145,704
137,468
227,539
253,915
Total Capitalization
145,704
137,468
227,539
253,915
Common Stock Equity
145,704
137,468
227,539
253,915
Capital Lease Obligations
--
--
139
236
Net Tangible Assets
145,667
137,292
226,917
252,840
Working Capital
124,782
115,438
204,163
231,948
Invested Capital
145,704
137,468
227,539
253,915
Tangible Book Value
145,667
137,292
226,917
252,840
Total Debt
--
--
139
236
Share Issued
47,976.1660
42,236.9190
41,735.5570
40,016.7920
Ordinary Shares Number
47,976.1660
42,236.9190
41,735.5570
40,016.7920
12/31/2021 - 1/8/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LIFE
ANVS Annovis Bio, Inc.
1.3000
+1.56%
AVXL Anavex Life Sciences Corp.
8.86
+3.75%
GLUE Monte Rosa Therapeutics, Inc.
4.2200
+1.69%
IKT Inhibikase Therapeutics, Inc.
2.0700
+11.29%
ABEO Abeona Therapeutics Inc.
4.6000
+10.05%
KTRA
SCPH scPharmaceuticals Inc.
2.3200
+15.14%
AXSM Axsome Therapeutics, Inc.
98.06
+2.52%
PIRS